申请人:MERCK FROSST CANADA INC.
公开号:EP0301692A3
公开(公告)日:1989-03-15
4,7-Benzofurandione derivatives of Formula I, pharmaceutical compositions, and methods of treatment are disclosed. These compounds are useful as inhibitors of mammalian leukotriene biosynthesis. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders, inflammation, psoriasis and allergic conjunctivitis. The compounds are also useful as analgesics and as cytoprotective agents. Also disclosed are novel intermediates useful for the preparation of the 4,7-benzofurandiones of this invention.
本文披露了公式I的4,7-苯并呋喃二酮衍生物、制药组合物和治疗方法。这些化合物可用作哺乳动物白三烯生物合成的抑制剂。因此,这些化合物是治疗过敏性疾病、哮喘、心血管疾病、炎症、银屑病和过敏性结膜炎的有用治疗剂。这些化合物也可用作镇痛剂和细胞保护剂。本文还披露了新型中间体,可用于制备本发明的4,7-苯并呋喃二酮。